Industry News

Raptor Pharmaceutical Corp. today announced that the company will release second quarter 2016 financial results on Thursday, August 4, 2016, after market close. Management will conduct a conference call and live audio webcast at 4:30 p.m. EDT that day to discuss the financial results and provide a corporate update.. Dial-in Number: 522-1023 International Dial-in Number: 815-6269 Conference ID: 46079703."/>
Raptor Pharmaceutical to Hold Second Quarter 2016 Financial Results Conference Call and Webcast on Thursday, August 4, 2016, at 4:30 p.m. EDT
Unilife Corporation today announced new management and Board appointments, a strategic focus on wearable injectors, and an update to its internal investigation. John Ryan, who has served as Interim Chief Executive Officer since March 2016 and Senior Vice President, General Counsel and Secretary since 2014, has been named President and Chief Executive Officer and appointed to the Board of Directors. Michael E. Kamarck, Ph.D., former President of..."/>
Unilife Announces New Leadership Team and Targeted Growth Strategy
Caladrius Biosciences, Inc., a cell therapy company combining an industry-leading development and manufacturing services provider, PCT, with a select therapeutic development pipeline, announces today that its product candidate CLBS03 was granted Fast Track designation by the US Food and Drug Administration for the treatment of type 1 diabetes mellitus, making it the first known therapeutic candidate for treatment of T1D to receive the..."/>
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
Chartwell Retirement Residences announced today that it has entered into a definitive agreement to acquire the 121- suite Tiffin House Retirement Residence in Midland, Ontario. Built in 2014 and located at 105 Pillsbury Drive, Tiffin House is a premier residence in an attractive and affluent neighbourhood on the east side of Midland, within close proximity to the waterfront of Midland Bay. The residence provides a full continuum of care with 48..."/>
Chartwell Announces Acquisition of a Modern Retirement Residence in Midland, Ontario
Teleflex Incorporated on Thursday announced the declaration by its board of directors of a quarterly cash dividend of USD0.34 per share of common stock. This dividend is payable on 15 September 2016 to shareholders of record at the close of business on 15 August 2016.. Teleflex is a provider of medical technologies designed to improve the health and quality of people's lives."/>
Teleflex’s board declares USD0.34 quarterly dividend
Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today announced that it will report its second quarter 2016 financial results prior to the NASDAQ market open on Thursday, August 4, 2016. Intercept management will conduct a conference call and audio webcast on Thursday, August 4, 2016 at 8:30 a.m. Eastern Time to discuss..."/>
Intercept to Report Second Quarter 2016 Financial Results on August 4 and Present at Upcoming Conference
RXi Pharmaceuticals Corporation, a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced that it will report its financial results for the second quarter ended June 30, 2016, and provide a business update on Thursday, August 11, 2016 after the close of the U.S. financial markets. A live audio webcast will begin at 4:30 p.m. EDT. The webcast link is available..."/>
RXi Pharmaceuticals to Webcast Second Quarter 2016 Financial Results on Thursday, August 11, 2016
Cerulean Pharma Inc., a clinical-stage company developing nanoparticle-drug conjugates, today announced it will provide an update on corporate activities for the second quarter 2016 on August 4.. Management will conduct a conference call at 4:30 p.m. ET that day to provide a business update and review the Company’ s second quarter financial results. This call can be accessed by dialing 831-3031 or 637-1284 prior to the start of the call and referencing..."/>
Cerulean to Host Second Quarter 2016 Conference Call on August 4
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery and development of novel therapeutic candidates that engage the body's ability to rebuild and repair its own cells and tissues, today announced that the Company will host a live conference call and webcast on Thursday, August 4, 2016 at 8:00 a.m. EDT to discuss its second quarter 2016 financial results and provide a corporate update. Participants can access the..."/>
Acceleron Pharma to Webcast Conference Call of Second Quarter 2016 Financial Results on August 4, 2016
Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to discuss the company's second quarter 2016 financial results and provide an operational update on Thursday, August 4, at 7:30 a.m. ET. The conference call will follow the anticipated..."/>
Amarin to Report Second Quarter 2016 Results and Host Conference Call at 7:30 A.M. ET on August 4, 2016
Dipexium Pharmaceuticals, Inc. will release its financial results for the quarter ended June 30, 2016, on Thursday, August 4, 2016 at 7:00 a.m. ET. The announcement will be followed by a conference call at 8:30 a.m. ET during which Dipexium management will discuss these results, recent developments and answer questions. To participate by telephone, please dial 877-407-8012 or 412-902-1013 five minutes prior to the start of the call."/>
Dipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET
ProMIS Neurosciences, a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced results in two presentations on its recent therapeutic developments at the Alzheimer's Association International Conference on July 27th, 2016 in Toronto, Ontario, Canada. "Our results presented at the AAIC meeting indicate that multiple monoclonal antibodies directed against five novel AD targets..."/>
ProMIS Neurosciences Announces Results in Two Presentations at the 2016 Alzheimer's Association International Conference
Sequenom, Inc.,, a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced on July 27, 2016 that it entered into a definitive agreement and plan of merger with Laboratory Corporation of America ® Holdings under which LabCorp would acquire all of the outstanding shares of Seqeunom in a cash tender offer. In light of this announcement, Sequenom has cancelled its second..."/>
Sequenom Announces Cancellation of Second Quarter 2016 Results Conference Call
Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., today announced Frank R. Williams, Jr. will join Adeptus Health's executive leadership as Executive Vice President and Chief Financial Officer. Williams will succeed Timothy L. Fielding, who has decided to pursue other business interests. Fielding will remain with the company through the end of September to ensure a smooth transition."/>
Adeptus Health Inc. Appoints Frank R. Williams, Jr. as Chief Financial Officer
West Pharmaceutical Services, Inc. today announced its financial results for the second quarter 2016 and updated financial guidance for the full-year 2016.. Reported net sales of $388.0 million grew 7.9% over the prior-year quarter. Net sales at constant currency grew by 8.2%. Second quarter 2016 reported diluted EPS was $0.60 as compared to $0.38 in the prior-year quarter."/>
West Announces Second Quarter 2016 Results
PDL BioPharma, Inc. today announced that the Company will release its second quarter 2016 financial results for the period ended June 30, 2016, on Thursday, August 4, 2016, after market close. PDL's management will host a conference call and webcast that day at 4:30 p.m. Eastern Time to discuss the financial results. A slide presentation relating to the call will be available via the webcast link on the PDL website."/>
PDL BioPharma to Announce Second Quarter 2016 Financial Results on August 4, 2016
Cambrex Reports Second Quarter 2016 Financial Results
CRH Medical Corporation, a North American medical company that provides physicians with essential services and innovative products for the prevention and treatment of gastrointestinal diseases, today announced its unaudited interim financial results for the quarter ended June 30, 2016. All financial results are expressed in U.S. dollars. Q2 and YTD 2016 Financial Highlights. June 30 June 30 YTD YTD 2016 2015 Change 2016 2015 Change----------------------------------------------------------------..."/>
CRH Medical Announces Second Quarter 2016 Results
Curis, Inc., a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced that the Company will release its first quarter 2016 financial results on Thursday, August 4, 2016, before the U.S. financial markets open. The Company's management will also host a conference call on the same day at 8:30 a.m. EDT.. To access the live conference call, please dial..."/>
Curis to Release Second Quarter 2016 Financial Results and Hold Conference Call on August 4, 2016
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2017 revenue of $103.0 million, an increase of 40% compared to revenue of $73.4 million for the same period of fiscal 2016. First quarter fiscal 2017 GAAP net income was $12.9 million or $0.29 per diluted share, compared to GAAP net income of $8.9 million or $0.20 per diluted share for the prior year period.. Financial and operating highlights..."/>
Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Financials956 Articles
Information Technology900 Articles
Consumer Discretionary752 Articles
Health Care597 Articles
Industrials597 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.